Franz Koenig

3.3k total citations
71 papers, 2.0k citations indexed

About

Franz Koenig is a scholar working on Statistics and Probability, Economics and Econometrics and Management Science and Operations Research. According to data from OpenAlex, Franz Koenig has authored 71 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Statistics and Probability, 25 papers in Economics and Econometrics and 14 papers in Management Science and Operations Research. Recurrent topics in Franz Koenig's work include Statistical Methods in Clinical Trials (38 papers), Health Systems, Economic Evaluations, Quality of Life (24 papers) and Optimal Experimental Design Methods (14 papers). Franz Koenig is often cited by papers focused on Statistical Methods in Clinical Trials (38 papers), Health Systems, Economic Evaluations, Quality of Life (24 papers) and Optimal Experimental Design Methods (14 papers). Franz Koenig collaborates with scholars based in Austria, Switzerland and United Kingdom. Franz Koenig's co-authors include Martin Posch, Péter Bauer, Werner Brannath, Frank Bretz, Markus Peck‐Radosavljevic, Ekkehard Glimm, Michael Branson, Cornelia Dunger‐Baldauf, Spiros Vamvakas and Stefan Fruehwald and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Franz Koenig

68 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franz Koenig Austria 24 946 483 459 379 356 71 2.0k
Melissa A. Robb United States 10 348 0.4× 555 1.1× 49 0.1× 235 0.6× 179 0.5× 12 2.2k
Didier Renard Belgium 21 633 0.7× 336 0.7× 98 0.2× 100 0.3× 108 0.3× 42 1.7k
Geraldine Rauch Germany 31 235 0.2× 141 0.3× 96 0.2× 347 0.9× 496 1.4× 138 2.6k
Arthur Allignol Germany 22 497 0.5× 264 0.5× 41 0.1× 358 0.9× 206 0.6× 52 2.0k
Aurélien Latouche France 24 444 0.5× 253 0.5× 36 0.1× 267 0.7× 273 0.8× 62 2.2k
Rachel E. Sherman United States 13 325 0.3× 524 1.1× 38 0.1× 167 0.4× 165 0.5× 18 2.1k
Song Zhang United States 31 153 0.2× 93 0.2× 43 0.1× 562 1.5× 456 1.3× 120 2.5k
Gene Pennello United States 17 278 0.3× 161 0.3× 35 0.1× 171 0.5× 280 0.8× 48 1.4k
Joseph S. Koopmeiners United States 28 305 0.3× 87 0.2× 123 0.3× 143 0.4× 115 0.3× 109 2.2k
Gerry Gray United States 6 239 0.3× 341 0.7× 27 0.1× 139 0.4× 142 0.4× 9 1.4k

Countries citing papers authored by Franz Koenig

Since Specialization
Citations

This map shows the geographic impact of Franz Koenig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz Koenig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz Koenig more than expected).

Fields of papers citing papers by Franz Koenig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz Koenig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz Koenig. The network helps show where Franz Koenig may publish in the future.

Co-authorship network of co-authors of Franz Koenig

This figure shows the co-authorship network connecting the top 25 collaborators of Franz Koenig. A scholar is included among the top collaborators of Franz Koenig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz Koenig. Franz Koenig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geurts, Marjolein, Franz Koenig, Burt Nabors, et al.. (2025). Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?. Neuro-Oncology Practice. 12(2). 291–300. 1 indexed citations
2.
Pericàs, Juan M., Nicholas A. Di Prospero, Quentin M. Anstee, et al.. (2023). Review article: The need for more efficient and patient‐oriented drug development pathways in NASH—setting the scene for platform trials. Alimentary Pharmacology & Therapeutics. 57(9). 948–961. 4 indexed citations
3.
4.
Antlanger, Marlies, Daniel Cejka, Kathrin Eller, et al.. (2023). Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design. Kidney International Reports. 9(2). 478–481. 3 indexed citations
5.
Melis, Guadalupe Gómez, et al.. (2022). Adaptive clinical trial designs with blinded selection of binary composite endpoints and sample size reassessment. arXiv (Cornell University). 2 indexed citations
6.
Ay, Cihan, Christian Schoergenhofer, Georg Gelbenegger, et al.. (2022). The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A. Blood. 141(10). 1147–1158. 18 indexed citations
7.
Burman, Carl‐Fredrik, Ekkehard Glimm, Stefan M. Gold, et al.. (2022). On model-based time trend adjustments in platform trials with non-concurrent controls. BMC Medical Research Methodology. 22(1). 228–228. 30 indexed citations
8.
Pawelka, Erich, Mario Karolyi, Sarah Ely, et al.. (2021). COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria. Infection. 49(5). 907–916. 12 indexed citations
9.
Berghoff, Anna S., Angelika M. Starzer, Nicolás Ballarini, et al.. (2020). Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer. European Journal of Cancer. 135. 150–158. 12 indexed citations
10.
Bayar, Mohamed Amine, Gwénaël Le Teuff, Franz Koenig, Marie‐Cécile Le Deley, & Stefan Michiels. (2019). Group sequential adaptive designs in series of time-to-event randomised trials in rare diseases: A simulation study. Statistical Methods in Medical Research. 29(6). 1483–1498. 2 indexed citations
11.
Jaki, Thomas, A. Gordon, Luc Bijnens, et al.. (2018). A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics. 17(5). 593–606. 4 indexed citations
12.
Collignon, Olivier, Franz Koenig, Armin Koch, et al.. (2018). Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency. Trials. 19(1). 642–642. 24 indexed citations
13.
Magirr, Dominic, Thomas Jaki, Franz Koenig, & Martin Posch. (2016). Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials. PLoS ONE. 11(2). e0146465–e0146465. 35 indexed citations
14.
Manolis, Efthymios, Ralf Herold, Franz Koenig, et al.. (2011). Role of modeling and simulation in pediatric investigation plans. Pediatric Anesthesia. 21(3). 214–221. 62 indexed citations
15.
Frottier, Patrick, et al.. (2009). The Distillation of “VISCI”: Towards a Better Identification of Suicidal Inmates. Suicide and Life-Threatening Behavior. 39(4). 376–385. 9 indexed citations
16.
Stallard, Nigel, Martin Posch, Tim Friede, Franz Koenig, & Werner Brannath. (2009). Optimal choice of the number of treatments to be included in a clinical trial. Statistics in Medicine. 28(9). 1321–1338. 15 indexed citations
17.
Weninger, Patrick, Silke Aldrian, Franz Koenig, V. Vécsei, & Thomas Nau. (2008). Functional Recovery at a Minimum of 2 Years After Multiple Injury—Development of an Outcome Score. The Journal of Trauma: Injury, Infection, and Critical Care. 65(4). 799–808. 22 indexed citations
18.
Koenig, Franz, Werner Brannath, Frank Bretz, & Martin Posch. (2007). Adaptive Dunnett tests for treatment selection. Statistics in Medicine. 27(10). 1612–1625. 85 indexed citations
19.
Brannath, Werner, Franz Koenig, & Péter Bauer. (2007). Multiplicity and flexibility in clinical trials. Pharmaceutical Statistics. 6(3). 205–216. 39 indexed citations
20.
Reisinger, Jürgen, Érika Calvano Küchler, Barbara Bohle, et al.. (2005). IFN-γ–enhanced allergen penetration across respiratory epithelium augments allergic inflammation. Journal of Allergy and Clinical Immunology. 115(5). 973–981. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa A. Robb Breakdown of academic impact, for papers by Didier Renard Breakdown of academic impact, for papers by Geraldine Rauch Breakdown of academic impact, for papers by Arthur Allignol Breakdown of academic impact, for papers by Aurélien Latouche Breakdown of academic impact, for papers by Rachel E. Sherman Breakdown of academic impact, for papers by Song Zhang Breakdown of academic impact, for papers by Gene Pennello Breakdown of academic impact, for papers by Joseph S. Koopmeiners Breakdown of academic impact, for papers by Gerry Gray
Rankless by CCL
2026